Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 618

Results For "AP"

8342 News Found

World BioProtection Forum India & Sharda University to host World BioProtection Summit – India 2022
Biotech | September 09, 2022

World BioProtection Forum India & Sharda University to host World BioProtection Summit – India 2022

Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector


Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally
Digitisation | September 08, 2022

Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally

Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes


President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9
Policy | September 08, 2022

President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9

The virtual event will be attended by representatives from state & district health administration, corporates, industries, civil society, and NGOs as the country reiterates its commitment towards TB elimination by 2025


Healthcare sector is expected to reach US $50 bn by 2025
News | September 08, 2022

Healthcare sector is expected to reach US $50 bn by 2025

Healthcare has become more focused on innovation and technology over the past two years and 80% of healthcare systems are aiming to increase their investment in digital healthcare tools in the coming five years


Lupin and DKSH sign licensing and supply agreement to market five biosimilar candidates in the Philippines
News | September 07, 2022

Lupin and DKSH sign licensing and supply agreement to market five biosimilar candidates in the Philippines

Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.


Mandaviya virtually lays Foundation Stone of NCDC branches in 6 states
Policy | September 07, 2022

Mandaviya virtually lays Foundation Stone of NCDC branches in 6 states

NCDC branches in States/UTs will provide a boost to Public Health Infrastructurewith prompt surveillance, rapid detection and timely monitoring of diseases enabling Early Interventions


Lonza and Touchlight collaborate on end-to-end mRNA offering
Biotech | September 07, 2022

Lonza and Touchlight collaborate on end-to-end mRNA offering

Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology


Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints
Clinical Trials | September 06, 2022

Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints

New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease


Artemis Hospitals opens new centre Daffodils by Artemis in Jaipur
Healthcare | September 06, 2022

Artemis Hospitals opens new centre Daffodils by Artemis in Jaipur

Daffodils by Artemis is a premiere luxury birthing centre offering mother and child care services.


InnoCare announces priority review of Orelabrutinib for the treatment of R/R MZL by NMPA
News | September 06, 2022

InnoCare announces priority review of Orelabrutinib for the treatment of R/R MZL by NMPA

Orelabrutinib is a highly selective BTK inhibitor developed by InnoCare for the treatment of cancers and autoimmune diseases.